Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 85051-85100 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06048926
Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma
NAEnrolling by invitation
30 participants
Started: Jul 30, 2022 · Completed: Jul 30, 2028
1 condition1 sponsor1 location
NCT05455307
Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture
NARecruiting
200 participants
Started: Jul 30, 2022 · Completed: Jul 30, 2027
3 conditions1 sponsor1 location
NCT05397587
An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)
PHASE4Not yet recruiting
474 participants
Started: Jul 30, 2022 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT05448066
Molecular Allergen Component Resolved Diagnosis to Decide Immunotherapy
NARecruiting
210 participants
Started: Jul 30, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT05417750
A Phase I Study on Autologous Tumor Infiltrating Lymphocytes Injection (GC101 TIL) for the Treatment of Advanced Malignant Solid Tumors
PHASE1Recruiting
60 participants
Started: Jul 30, 2022 · Completed: Apr 30, 2026
6 conditions1 sponsor1 location
NCT05303467
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
PHASE1Recruiting
36 participants
Started: Jul 30, 2022 · Completed: Jun 1, 2026
2 conditions1 sponsor9 locations
NCT05459948
The Medacta GMK SpheriKA Post-Marketing Surveillance Study
N/ARecruiting
281 participants
Started: Jul 30, 2022 · Completed: May 31, 2035
2 conditions1 sponsor4 locations
NCT05033756
Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO
PHASE2Active, not recruiting
11 participants
Started: Jul 30, 2022 · Completed: Feb 28, 2026
2 conditions2 sponsors6 locations
NCT05811845
Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALL
N/ARecruiting
250 participants
Started: Jul 30, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT05707819
Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
N/ARecruiting
43 participants
Started: Jul 30, 2022 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT05002478
Infants with Severe Acute Respiratory Distress Syndrome: the Prone Trial
NARecruiting
14 participants
Started: Jul 30, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05124236
Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases
NARecruiting
200 participants
Started: Jul 29, 2022 · Completed: Dec 30, 2025
1 condition2 sponsors8 locations
NCT06154902
Real-World Outcomes in Relapsed/Refractory Multiple Myeloma Patients Treated, or Eligible for Treatment, With Idecabtagene Vicleucel
N/AActive, not recruiting
350 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05394766
Remote Patient Monitoring and Health Coaching vs. Usual Care for the Treatment of Hypertension
NARecruiting
550 participants
Started: Jul 29, 2022 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT05595473
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular Carcinoma
PHASE1/PHASE2Active, not recruiting
42 participants
Started: Jul 29, 2022 · Completed: May 31, 2029
1 condition1 sponsor5 locations
NCT06488209
Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease
PHASE1Recruiting
72 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor3 locations
NCT05363046
Noninterventional Study Evaluating Parkinson's Disease Diary Use
N/AActive, not recruiting
194 participants
Started: Jul 29, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor34 locations
NCT06978985
Adult SMA Research and Clinical Hub
N/ARecruiting
600 participants
Started: Jul 29, 2022 · Completed: Apr 30, 2027
1 condition5 sponsors18 locations
NCT05379595
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
PHASE1/PHASE2Recruiting
225 participants
Started: Jul 29, 2022 · Completed: Oct 31, 2031
1 condition1 sponsor53 locations
NCT05240014
Enhancing Voluntary Motion in Broad Patient Populations With Modular Powered Orthoses
NARecruiting
33 participants
Started: Jul 29, 2022 · Completed: Sep 21, 2026
3 conditions2 sponsors1 location
NCT04959695
Evaluation of the PE Coach Mobile Application Among Veterans With PTSD
NARecruiting
124 participants
Started: Jul 29, 2022 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT06108999
Management of Acute and Chronic Wounds With Hyaluronic Acid
NARecruiting
170 participants
Started: Jul 29, 2022 · Completed: Sep 30, 2024
2 conditions1 sponsor3 locations
NCT06868771
Study on the Effectiveness of an Emollient Cream Containing Pre and Postbiotic and Niacinamide 4% in the Treatment of Skin Xerosis and Itching in Oncological Patients Treated with Anti-EGFR
NARecruiting
164 participants
Started: Jul 29, 2022 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05222984
Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax
PHASE1Active, not recruiting
17 participants
Started: Jul 29, 2022 · Completed: Apr 2, 2026
2 conditions2 sponsors1 location
NCT06758271
Special Drug Use-results Survey for Long-term Use(Avacopan)
N/ARecruiting
250 participants
Started: Jul 29, 2022 · Completed: May 31, 2028
2 conditions1 sponsor1 location
NCT05727163
FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
PHASE2Recruiting
194 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05288985
Impact of Loco-regional Analgesia Following Placement of Erector Spinae Plane Catheter in Addition to Systemic Analgesia in Patients With Thoracic Trauma
NARecruiting
40 participants
Started: Jul 29, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05489783
Glioma Developmental and HyperActive Ras Tumor (DHART) Board
N/ARecruiting
50 participants
Started: Jul 29, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor7 locations
NCT05389215
Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
PHASE2Recruiting
102 participants
Started: Jul 29, 2022 · Completed: Jan 30, 2027
1 condition1 sponsor30 locations
NCT05457257
Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations
PHASE4Active, not recruiting
43 participants
Started: Jul 29, 2022 · Completed: Sep 30, 2025
1 condition4 sponsors35 locations
NCT06589869
Effect of High-Intensity Focused Electromagnetic (HIFEM) Technology in the Treatment of SUI in Chinese Men Undergone Robotic Radical Prostatectomy
NARecruiting
184 participants
Started: Jul 29, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05451901
Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis
NARecruiting
70 participants
Started: Jul 29, 2022 · Completed: Apr 11, 2031
4 conditions1 sponsor21 locations
NCT05384769
Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
NARecruiting
108 participants
Started: Jul 29, 2022 · Completed: Jan 28, 2029
1 condition2 sponsors1 location
NCT05459090
Functional Study of Inhibitory Neurotransmission in the Human Epileptic Brain.
N/ARecruiting
60 participants
Started: Jul 29, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05420844
Pilot Study to Evaluate a Voice Journaling Application in Adolescents With Cystic Fibrosis
NAActive, not recruiting
30 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05221931
Drug-Coated Balloon in Patients With High Bleeding Risk
NARecruiting
1,350 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2028
1 condition17 sponsors17 locations
NCT06899789
Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis
N/ARecruiting
250 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT05402579
Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk
N/ARecruiting
60 participants
Started: Jul 29, 2022 · Completed: Feb 1, 2025
3 conditions4 sponsors2 locations
NCT05500755
Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants
N/ARecruiting
150 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03999853
Butyrate Adjuvant Therapy for Type 1 Diabetes
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05118477
vHDU Phase 5: Impact of an Ambulatory Monitoring System on Deterioration Detection and Clinical Outcomes
NARecruiting
120 participants
Started: Jul 28, 2022 · Completed: Mar 31, 2025
2 conditions2 sponsors1 location
NCT06272292
Biomechanical Investigation of Symptomatic FAI and Two Groups of Asymptomatic Controls
NARecruiting
99 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05462587
A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients with Leukocyte Adhesion Deficiency Type II
PHASE3Recruiting
4 participants
Started: Jul 28, 2022 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT05475262
Sleepless at Scripps: An Inpatient White Noise Study
NARecruiting
50 participants
Started: Jul 28, 2022 · Completed: Feb 1, 2027
4 conditions1 sponsor1 location
NCT05167409
A Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
PHASE2Active, not recruiting
48 participants
Started: Jul 28, 2022 · Completed: Mar 1, 2026
1 condition6 sponsors4 locations
NCT04929951
The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis
PHASE1Recruiting
48 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05285878
Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
PHASE2Enrolling by invitation
20 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2027
7 conditions1 sponsor1 location
NCT05024760
Antiseptic Effects on the Dental Implant Internal Surface Microbiome
EARLY_PHASE1Recruiting
150 participants
Started: Jul 28, 2022 · Completed: Nov 30, 2025
4 conditions2 sponsors1 location
NCT05825508
PedBot Ankle Rehablitation
N/AActive, not recruiting
20 participants
Started: Jul 28, 2022 · Completed: Jul 28, 2025
1 condition1 sponsor1 location
NCT05312983
Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss
NARecruiting
700 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2030
1 condition3 sponsors2 locations